The Role of the Genial Bone Advancement Trephine System in Conjunction with Uvulopalatopharyngoplasty in the Multilevel Management of Obstructive Sleep Apnea

Miller, Frank R.; Watson, Daniel W.; Boseley, Mark E.

doi:10.1016/j.otohns.2003.09.015

Cited by 60 publications

(42 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…7,10 Some authors have defined surgical success or cure after UPPP as a 50% reduction in the AHI, whereas others combine this criterion with an absolute AHI of 20 or less. [11][12][13][14] Unfortunately, use of these criteria means that successfully treated patients may still have mild to moderate residual OSA. Increasing evidence shows that, when treating OSA, reducing the AHI to less than 5 is necessary to improve health care-related outcome measures, such as hypertension.…”

Section: Resultsmentioning

confidence: 99%

Uvulopalatopharyngoplasty in the Management of Obstructive Sleep Apnea: The Mayo Clinic Experience

Khan

Ramar

Maddirala

et al. 2009

Mayo Clinic Proceedings

View full text Add to dashboard Cite

O bstructive sleep apnea (OSA) is highly prevalent, affecting 4% of men and 2% of women who meet a disease-defining threshold of at least 5 episodes of apnea or hypopnea per hour of sleep (apnea-hypopnea index [AHI] ≥5) and excessive daytime sleepiness.1 Continuous positive airway pressure (CPAP), a technique that pneumatically supports the upper airway, is a therapeutic mainstay for OSA. It has been shown to reduce the AHI, improve sleepiness and quality of life, and reduce cardiovascular risk.2,3 Despite demonstrable benefits and technological equipment advances, compliance with CPAP therapy varies, with 29% to 83% of patients using CPAP for less than 4 hours a night in various studies. 4

show abstract

Section: Resultsmentioning

confidence: 99%

Uvulopalatopharyngoplasty in the Management of Obstructive Sleep Apnea: The Mayo Clinic Experience

Khan

Ramar

Maddirala

et al. 2009

Mayo Clinic Proceedings

View full text Add to dashboard Cite

show abstract

“…There is no data on the eVectiveness of GA as an independent treatment modality. The known risks of GA are long lasting numbness of the lower central incisors, exposure of plates and screws and Xoor of mouth hematomas [28]. MMA is probably the most successful operation for OSAS, but its morbidity is considerable.…”

Section: Discussionmentioning

confidence: 99%

Complications of hyoid suspension in the treatment of obstructive sleep apnea syndrome

Richard

Timmer

Vries

2010

Eur Arch Otorhinolaryngol

View full text Add to dashboard Cite

The objectives of the study are to assess adverse events and complications of hyoid suspension (HS) as a treatment of obstructive sleep apnea syndrome (OSAS). The study design was cohort. Thirty-nine patients with OSAS and obstruction at tongue base level, as assessed by sleep endoscopy, underwent HS. Information about adverse events and complications were obtained by reviewing charts and patient-completed questionnaires. The mean follow-up period from surgery to last control visit was 13.1 months (range 2-38). The charts demonstrated mainly adverse events. Minor complications occurred in six patients. No major complications were observed. The mean admission duration was 3.3 days (range 2-5). Twenty-six patients (67%) returned their questionnaires. No association was found between completing questionnaires and the success of the intervention (p = 0.73). The questionnaires were completed on average 25.9 months (range 3.5-51.5) after surgery. VAS scores showed a fast decline in complaints regarding taste, speech, swallowing and pain. No significant long-term differences were found, when comparing the postoperative VAS scores with the preoperative VAS scores. Of the 26 evaluable questionnaires, 20 patients (77%) would recommend HS to an acquaintance if they suffered from sleep apnea syndrome, when only taking side effects into consideration. The intention to give a positive recommendation did not seem to be related to the therapeutic success of the intervention. In conclusion, this study demonstrates that the complication rate of HS is low and that the discomfort is very acceptable.

show abstract

“…Genioglossal advancement, radiofrequency ablation of the tongue, partial midline glossectomy, lingual tonsillectomy are all surgical options that are aimed at improving oropharyngeal and hypopharyngeal obstruction with varying degrees of reported success. [82][83][84][85][86][87] Rapid maxillary expansion devices have been described in prepubertal children in an effort to widen the hard palate and enlarge the nasal cavity. Villa and colleagues 88,89 reported that, in 14 children, a mean expansion of 3.7 mm for the intercanine distance and 5.0 mm for the interpremolar distance led to an improvement in AHI from 5.8 to 1.5 events per hour, a reduction in snoring, and a reduction in daytime symptoms; this improvement was found to be persistent at 24-month follow-up PSG.…”

Section: Persistent Osasmentioning

confidence: 99%

Pediatric Obstructive Sleep Apnea Syndrome

Schroeder

2013

Pediatric Clinics of North America

View full text Add to dashboard Cite

The Role of the Genial Bone Advancement Trephine System in Conjunction with Uvulopalatopharyngoplasty in the Multilevel Management of Obstructive Sleep Apnea

Cited by 60 publications

References 24 publications

Uvulopalatopharyngoplasty in the Management of Obstructive Sleep Apnea: The Mayo Clinic Experience

Uvulopalatopharyngoplasty in the Management of Obstructive Sleep Apnea: The Mayo Clinic Experience

Complications of hyoid suspension in the treatment of obstructive sleep apnea syndrome

Pediatric Obstructive Sleep Apnea Syndrome

Contact Info

Product

Resources

About